Ondine Biomedical Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
8,000
- Stock Symbol
-
OBI
- Investments
-
3
- Share Price
-
$0.12
- (As of Thursday Closing)
Ondine Biomedical General Information
Description
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
Contact Information
Website
www.ondinebio.comCorporate Office
- 1100 Melville Street
- Suite 888
- Vancouver, British Columbia V6E 4A6
- Canada
Corporate Office
- 1100 Melville Street
- Suite 888
- Vancouver, British Columbia V6E 4A6
- Canada
Ondine Biomedical Timeline
Ondine Biomedical Stock Performance
As of 12-Nov-2026, Ondine Biomedical’s stock price is $0.12. Its current market cap is $79.9M with 661M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.12 | $0.12 | $0.10 - $0.21 | $79.9M | 661M | 711K | -$0.04 |
Ondine Biomedical Financials Summary
As of 30-Jun-2026, Ondine Biomedical has a trailing 12-month revenue of $2.08M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 96,220 | 53,900 | 46,169 | 22,436 |
| Revenue | 2,082 | 1,892 | 1,494 | 891 |
| EBITDA | (23,700) | (20,931) | (13,504) | (10,388) |
| Net Income | (23,959) | (21,106) | (13,927) | (10,672) |
| Total Assets | 6,254 | 10,500 | 8,934 | 4,322 |
| Total Debt | 195 | 302 | 117 | 408 |
Ondine Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ondine Biomedical Comparisons
Industry
Financing
Details
Ondine Biomedical Competitors (11)
One of Ondine Biomedical’s 11 competitors is Amnio Technology, a Formerly Accelerator/Incubator backed company based in Phoenix, AZ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Amnio Technology | Formerly Accelerator/Incubator backed | Phoenix, AZ | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA | ||||
| Athersys | Formerly VC-backed | Cleveland, OH | ||||
| Providence Therapeutics | Venture Capital-Backed | Calgary, Canada |
Ondine Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ondine Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ondine Biomedical Investments & Acquisitions (3)
Ondine Biomedical’s most recent deal was a Seed Round with Guaranteed (Clinics/Outpatient Services) for . The deal was made on 03-Nov-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Guaranteed (Clinics/Outpatient Services) | 03-Nov-2022 | Seed Round | Clinics/Outpatient Services | ||
| Advanced Photodynamic Technologies | 19-Nov-2009 | Merger/Acquisition | Therapeutic Devices | ||
| Springbank Ventures | 01-Apr-2004 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Ondine Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Ondine Biomedical FAQs
-
When was Ondine Biomedical founded?
Ondine Biomedical was founded in 1996.
-
Where is Ondine Biomedical headquartered?
Ondine Biomedical is headquartered in Vancouver, Canada.
-
What is the size of Ondine Biomedical?
Ondine Biomedical has 8,000 total employees.
-
What industry is Ondine Biomedical in?
Ondine Biomedical’s primary industry is Therapeutic Devices.
-
Is Ondine Biomedical a private or public company?
Ondine Biomedical is a Public company.
-
What is Ondine Biomedical’s stock symbol?
The ticker symbol for Ondine Biomedical is OBI.
-
What is the current stock price of Ondine Biomedical?
As of 12-Nov-2026 the stock price of Ondine Biomedical is $0.12.
-
What is the current market cap of Ondine Biomedical?
The current market capitalization of Ondine Biomedical is $79.9M.
-
What is Ondine Biomedical’s current revenue?
The trailing twelve month revenue for Ondine Biomedical is $2.08M.
-
Who are Ondine Biomedical’s competitors?
Amnio Technology, Astellas Pharma, Vir Biotechnology, Athersys, and Providence Therapeutics are some of the 11 competitors of Ondine Biomedical.
-
What is Ondine Biomedical’s annual earnings per share (EPS)?
Ondine Biomedical’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
